-
All Resources
(choose a category)
-
All Resources
-
selected
Evidence
Evidence, advice, guidance and standards
-
Improvement
Improvement and implementation support
-
selected
Scrutiny
Assurance, scrutiny, measurement and reporting
-
-
Healthcare Area
- Blood and immune system
- Cancer
- Cardiovascular system
- Dermatology
- Digestive system
- Ear, nose and throat
- Endocrine, nutritional and metabolic
- Eye
- Genitourinary system
- Infectious disease
- Injuries, accidents and wounds
- Mental and behavioural disorders
- Mouth and dental
- Musculoskeletal system
- Nervous system
- Obstetrics and gynaecology
- Respiratory system
-
Resource Type
- NICE Guidance
- Programme
- Year
- prev
- Page 9 of 3
29 results found filtered by Evidence Remove Evidence Filter Scrutiny Remove Scrutiny Filter 2012 Remove 2012 Filter 2008 Remove 2008 Filter 2010 Remove 2010 Filter NICE Guidance Remove NICE Guidance Filter Clear Search
-
NICE STA Guidance no 268 - Ipililmumab for previously treated advanced (unresectable or metastatic) melanoma
- Published
- 12 December 2012
- Cycle of Improvement
- Evidence
-
NICE STA Guidance No 270 – Leukaemia (acute myeloid ) – decitabine (terminated appraisal)
- Published
- 12 December 2012
- Cycle of Improvement
- Evidence
-
NICE STA Guidance no 269 Vemurafenib for advanced or metastatic BRAF V600 mutation-positive malignant melanoma
- Published
- 11 December 2012
- Cycle of Improvement
- Evidence
-
NICE STA Guidance No 266 - mannitol dry powder for inhalation for treating cystic fibrosis
- Published
- 28 November 2012
- Cycle of Improvement
- Evidence
-
NICE STA Guidance no 267 – ivabradine for treating chronic heart failure
- Published
- 28 November 2012
- Cycle of Improvement
- Evidence
-
NICE MTA Guidance 265 - Bone metastases from solid tumours - denosumab
- Published
- 24 October 2012
- Cycle of Improvement
- Evidence
-
NICE STA Guidance No 264 – Alteplase for treating acute ischaemic stroke
- Published
- 25 September 2012
- Cycle of Improvement
- Evidence
-
NICE STA Guidance 263 - Bevacizumab in combination with capecitabine for metastatic breast cancer
- Published
- 22 August 2012
- Cycle of Improvement
- Evidence
-
NICE STA Guidance 261 – Rivaroxaban for the treatment of deep vein thrombosis
- Published
- 25 July 2012
- Cycle of Improvement
- Evidence
-
NICE STA Guidance 262 – Adalimumab for the treatment of moderate to severe ulcerative colitis
- Published
- 25 July 2012
- Cycle of Improvement
- Evidence